glp 1 law The GLP-1 RA Legal Timeline: How Serious Side Effects Led to Multidistrict Litigation The effort marks a notable

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish drugmaker Novo Nordisk that should expand access to its in-demand GLP-1 at the expense of Eli Lillys.

Ozempic and other GLP-1 receptor agonists have rapidly become some of the most talked-about medications in the management of type 2 diabetes and weight-relat...

Tailor payer engagement strategies to the specific behaviors and cost controls of individual payers, recognizing that access and restrictions vary widely

In the latest issue of Vitalstoffe, a leading German trade publication focused on scientifically backed dietary supplement ingredients, Gateway Health Alliances President Shil Kothari highlights the critical roles of adiponectin, leptin, and insulin.

Prices in CAD